2020
DOI: 10.14738/aivp.83.8650
|View full text |Cite
|
Sign up to set email alerts
|

HIV and the Antiviral Role of Mushroom Nutraceuticals

Abstract: He is currently a lecturer in the Department of Bioscience (graded 5 in the recent National Research exercise) at the University of Strathclyde. He has authored or coauthored 25 research papers that have appeared in internationally-assessed Journals. His current research interests encompass the fields of Biomedical and Food Microbiology, including studies on the detection of microbial pathogens in foods for susceptible groups, the virulence properties of food-borne pathogens, and on resources that can be used … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 107 publications
(135 reference statements)
0
3
0
Order By: Relevance
“…Similarly, compounds detected in L. squarrosulus, A. auricular-judae, P. ostreatus and V. volvacea has pedigree of antiviral activities against Human Immune Deficiency Virus (HIV) virus while A. auricular-judae, M. copelandii, B. myosura, P. ostreatus and V. volvacea synthesizes compounds with anticancer, cancer preventive, antitumor and anti-inflammatory activities. This suggests the potential of these mushrooms in foiling infectious diseases caused by viruses [28]- [31], as well as an immunomodulators in cancer immunotherapy and anti-hyperplasia and hypertrophic cell growth [32]- [34]. Similarly, the presences of Undecane; Noxiptiline and 9,17-Octadecadienal, (Z) with reported antimicrobial activities in M. copelandii and V. volvacea, reveals the potential of this species as a source of probiotic compounds in the management of infectious disease [25], [35], [36].…”
Section: Discussionmentioning
confidence: 97%
“…Similarly, compounds detected in L. squarrosulus, A. auricular-judae, P. ostreatus and V. volvacea has pedigree of antiviral activities against Human Immune Deficiency Virus (HIV) virus while A. auricular-judae, M. copelandii, B. myosura, P. ostreatus and V. volvacea synthesizes compounds with anticancer, cancer preventive, antitumor and anti-inflammatory activities. This suggests the potential of these mushrooms in foiling infectious diseases caused by viruses [28]- [31], as well as an immunomodulators in cancer immunotherapy and anti-hyperplasia and hypertrophic cell growth [32]- [34]. Similarly, the presences of Undecane; Noxiptiline and 9,17-Octadecadienal, (Z) with reported antimicrobial activities in M. copelandii and V. volvacea, reveals the potential of this species as a source of probiotic compounds in the management of infectious disease [25], [35], [36].…”
Section: Discussionmentioning
confidence: 97%
“…Also, 6-Ethyl-5,6-dihydro-2H-pyran-2-one and 5,6-Diphenyl-4,5-dihydro-1,2,4-triazin-3(2H)-one detected in D. concentrica has been reported to possess antiviral activities against Human Immune Deficiency Virus (HIV) virus whereas all the study mushrooms except T. versicolor, synthesizes compounds with cancer-preventive, antitumor and anti-inflammatory activities. This suggests the potential of these mushrooms and their products in foiling infectious diseases caused by viruses [51]- [54], as well as an immunomodulator in cancer immunotherapy and antihyperplasia, and hypertrophic cell growth [55]- [57].…”
Section: Discussionmentioning
confidence: 98%
“…We have previously reviewed this subject [134], and the pathogenesis of the disease is considered multifactorial. Nutrition is a fundamental part of a comprehensive package of care for people living with HIV/AIDS, and mushrooms supply bioactive molecules that may help patients [110].…”
Section: Hiv/aidsmentioning
confidence: 99%